Tumorigenesis and the angiogenic switch

Bergers, Gabriele, Benjamin, Laura E.·2003·Nature reviews. Cancer

Cited by (1,010)

Items 201–300 of 1,010

  1. Molecular Insight of Regorafenib Treatment for Colorectal Cancer
    Arai, Hiroyuki, Battaglin, Francesca, Wang, Jingyuan, Lo, Jae Ho, Soni, Shivani, Zhang, Wu, Lenz, Heinz-Josef · 2019 · Cancer Treatment Reviews
  2. Angiogenesis in pre-malignant conditions
    Marius Raica, Anca Maria Cîmpean, Doménico Ribatti · 2009 · European Journal of Cancer
  3. Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo
    Jürgen K. Willmann, Amelie M. Lutz, Ramasamy Paulmurugan, Manishkumar R. Patel, Pauline Chu, Jarrett Rosenberg, Sanjiv Sam Gambhir · 2008 · Radiology
  4. YB-1: oncoprotein, prognostic marker and therapeutic target?
    Annette Lasham, Cristin Gregor Print, Adele G. Woolley, Sandra Elaine Dunn, Antony W. Braithwaite · 2012 · Biochemical Journal
  5. The dual role of thymidine phosphorylase in cancer development and chemotherapy
    Annelies Bronckaers, Federico Gago, Jan M. Balzarini, Sandra Liekens · 2009 · Medicinal Research Reviews
  6. MMP‐2 alters VEGF expression via αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cells
    Chandramu Chetty, Sajani S. Lakka, Praveen Bhoopathi, Jasti Sambasiva Rao · 2009 · International Journal of Cancer
  7. Deciphering p53 signaling in tumor suppression
    Stephano S. Mello, Laura Donatella Attardi · 2017 · Current Opinion in Cell Biology
  8. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
    Gerhard Fürstenberger, Roger von Moos, Rudolf Lucas, Beat J. K. Thurlimann, H-J Senn, Jürg Hamacher, E-M Boneberg · 2006 · British Journal of Cancer
  9. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
    Gürcan Günaydın · 2021 · Frontiers in Oncology
  10. S100 protein family in human cancer.
    Hongyan Chen, Chengshan Xu, Qing'e Jin, Zhihua Liu · 2014 · Europe PMC (PubMed Central)
  11. Recent advances in molecular, multimodal and theranostic ultrasound imaging
    Fabian M. Kiessling, Stanley Fokong, Jessica Bzyl, Wiltrud Lederle, Moritz Palmowski, Twan Lammers · 2013 · Advanced Drug Delivery Reviews
  12. Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH
    Giulia Taraboletti, Sandra D'Ascenzoy, Ilaria Giusti, Daniela Marchetti, Patrizia Borsotti, Danilo Millimaggi, Raffaella Giavazzi, Antonio Pavan, Vincenza Dolo · 2006 · Neoplasia
  13. Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions
    Giampietro Gasparini, Raffaele Longo, Massimo Fanelli, Beverly A. Teicher · 2005 · Journal of Clinical Oncology
  14. Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease
    Jermaine Goveia, Peter Conrad Stapor, Peter Carmeliet · 2014 · EMBO Molecular Medicine
  15. Visualizing breast cancer using the Twente photoacoustic mammoscope: What do we learn from twelve new patient measurements?
    Michelle Heijblom, Daniele Piras, Wenfeng Xia, Johan C. G. van Hespen, J.M. Klaase, Frank M. van den Engh, Ton G. J. M. van Leeuwen, Wiendelt Steenbergen, Srirang Manohar · 2012 · Optics Express
  16. Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study
    Leonora S. F. Boogerd, Charlotte E.S. Hoogstins, Dennis P. Schaap, Miranda Kusters, Henricus J.M. Handgraaf, Maxime J.M. van der Valk, Denise E. Hilling, Fabian A. Holman, Koen C.M.J. Peeters, J. Sven D. Mieog et al. · 2018 · The Lancet. Gastroenterology & hepatology
  17. The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
    Diana Klein · 2018 · Frontiers in Oncology
  18. A three-dimensional in vitro model of tumor cell intravasation
    Ehsan, Seema M., Welch-Reardon, Katrina M., Waterman, Marian L., Hughes, Christopher C. W., George, Steven C. · 2014 · Integrative Biology
  19. Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
    Yuling Li, Yuling Li, Hua Zhao, Xiubao Ren, Hua Zhao, Xiubao Ren · 2016 · Cancer Biology and Medicine
  20. Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy
    Rajesh Nivarti Gacche, Rohan J. Meshram · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  21. Peptide Targeted Lipid Nanoparticles for Anticancer Drug Delivery
    Timothy R. Pearce, Kamlesh Shroff, Efrosini Kokkoli · 2012 · Advanced Materials
  22. The role of imaging in the management of progressive glioblastoma
    Timothy Charles Ryken, Nafi Aygün, Johnathan Morris, Marin Leigh Schweizer, Rajeshwari Nair, Cassandra Nichole Spracklen, Steven N. Kalkanis, Jeffrey J. Olson · 2014 · Journal of Neuro-Oncology
  23. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells
    Isabelle Corre, François Paris, Jacques Huot · 2017 · Oncotarget
  24. Immunomodulatory Activity of VEGF in Cancer
    Alexandra Lapeyre-Prost, Magali Terme, Simon Pernot, Anne‐Laure Pointet, Thibault Voron, Éric Tartour, Julien Taı̈eb · 2016 · International review of cytology
  25. Targeted Polymeric Micelles for siRNA Treatment of Experimental Cancer by Intravenous Injection
    R. James Christie, Yu Matsumoto, Kanjiro Miyata, Takahiro Nomoto, Shigeto Fukushima, Kensuke Osada, Julien Halnaut, Frederico Pittella, Hyun Jin Kim, Nobuhiro Nishiyama et al. · 2012 · ACS Nano
  26. Cancer Drug Discovery and Development
    Jeffrey S. Humphrey, Karen Price, Elora Gupta, Andrew R. W. Baxter, John Bird, Daryl S. Sonnichsen, Joseph G. Naglich · 2003 · Humana Press eBooks
  27. Targeting the tumour vasculature: from vessel destruction to promotion
    Sophie Guelfi, Kairbaan Hodivala‐Dilke, Gabriele Bergers · 2024 · Nature reviews. Cancer
  28. CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells
    Tao Wang, Yvona Ward, Linhua Tian, Ross G. Lake, Liliana Guédez, William George Stetler‐Stevenson, Kathleen Kelly · 2004 · Blood
  29. Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer
    Aparna A. Kamat, William M. Merritt, Donna Coffey, Yvonne Gail Lin, Pooja R. Patel, Russell R. Broaddus, Elizabeth K. Nugent, Liz Y. Han, Charles N. Landen, Whitney A. Spannuth et al. · 2007 · Clinical Cancer Research
  30. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance
    Lim, Kian-Huat, Counter, Christopher M. · 2005 · Cancer Cell
  31. Contribution of adipose tissue to development of cancer
    Cozzo, Alyssa J., Fuller, Ashley M., Makowski, Liza · 2017 · Comprehensive Physiology
  32. Tenascins in stem cell niches
    Ruth Chiquet‐Ehrismann, Gertraud Orend, Matthias Chiquet, Richard P. Tucker, Kim S. Midwood · 2014 · Matrix Biology
  33. Pathophysiological Basis for the Formation of the Tumor Microenvironment
    Michael R. Horsman, Peter W. Vaupel · 2016 · Frontiers in Oncology
  34. TGF-β suppresses type 2 immunity to cancer
    Ming Liu, Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi, Chun Chou, Mytrang H. Do, Efstathios G. Stamatiades, Shengyu Gao et al. · 2020 · Nature
  35. MicroRNAs in the Pathogenesis of Cancer
    Francesca Lovat, Nicola Valeri, Carlo Maria Croce · 2011 · Seminars in Oncology
  36. In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3
    Weibo Cai, Yun Wu, Kai Chen, Qizhen Cao, David A. Tice, Xiaoyuan Shawn Chen · 2006 · Cancer Research
  37. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia
    Shi-Young Park, Won‐Jun Jang, Eui-Yeun Yi, Ji-Yeong Jang, Yunjin Jung, Joo‐Won Jeong, Yung-Jin Kim · 2010 · Journal of Pineal Research
  38. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan
    Uğur Özerdem, William B. Stallcup · 2004 · Angiogenesis
  39. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1
    Moon‐Kyoung Bae, Se‐Hee Kim, Joo‐Won Jeong, You Jin Lee, Hae-Sun Kim, Su-Ryun Kim, Il Yun, Soo‐Kyung Bae, Kyu‐Won Kim · 2006 · Oncology Reports
  40. Biological significance of c-erbB family oncogenes in head and neck cancer
    Susanne J. Rogers, Kevin Joseph Harrington, Peter H. Rhys‐Evans, Pornchai O‐charoenrat, Suzanne A. Eccles · 2005 · Cancer and Metastasis Reviews
  41. Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
    Sanjaykumar Hapani, Amna Falak Sher, David T. W. Chu, Shenhong Wu · 2010 · Oncology
  42. Using Functional Nanomaterials to Target and Regulate the Tumor Microenvironment: Diagnostic and Therapeutic Applications
    Tianjiao Ji, Ying Zhao, Yanping Ding, Guangjun Nie · 2013 · Advanced Materials
  43. Nanoparticles as new tools for inhibition of cancer angiogenesis
    Nasser Hashemi Goradel, Farshid Ghiyamihoor, Samira Jahangiri, Babak Negahdari, Amirhossein Sahebkar, Aria Masoudifar, Hamed Mirzaei · 2017 · Journal of Cellular Physiology
  44. Synthesis, bioactive properties, and biomedical applications of intrinsically therapeutic nanoparticles for disease treatment
    Duc Dung Nguyen, Jui‐Yang Lai · 2022 · Chemical Engineering Journal
  45. Exosome: A Novel Approach to Stimulate Bone Regeneration through Regulation of Osteogenesis and Angiogenesis
    Yunhao Qin, Ruixin Sun, Chuanlong Wu, Lian Y. Wang, Changqing Zhang · 2016 · International Journal of Molecular Sciences
  46. Current landscape and future directions of bispecific antibodies in cancer immunotherapy
    Jing Wei, Yueyao Yang, Gang Wang, Ming Liu · 2022 · Frontiers in Immunology
  47. Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
    Anne Maria Schultheis, Georg Lurje, Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Agustin A. García, Robert J. Morgan, David R. Gandara, Sidney Scudder, Amit M. Oza et al. · 2008 · Clinical Cancer Research
  48. A YKL-40–Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
    Michael Faibish, Ralph A. Francescone III, Brooke Bentley, Wei Yan, Rong Shao · 2011 · Molecular Cancer Therapeutics
  49. RETRACTED: Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells
    Haiou Yang, Haiyang Zhang, Shaohua Ge, Tao Ning, Ming Bai, Jialu Li, Shuang Li, Wu Sun, Ting Deng, Le Zhang et al. · 2018 · Molecular Therapy · Retracted
  50. Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
    M. Abdel Aziz, Rabah A.T. Serya, Deena S. Lasheen, Amal Kamal Abdel‐Aziz, Ahmed Esmat, Ahmed M. Mansour, Abdel Nasser B. Singab, Khaled A. M. Abouzid · 2016 · Scientific Reports
  51. Dormancy in cancer
    Hiroko Endo, Masahiro Inoue · 2018 · Cancer Science
  52. The hallmarks of cancer are also the hallmarks of wound healing
    Lucy MacCarthy‐Morrogh, Paul B. Martin · 2020 · Science Signaling
  53. Current concepts in clinical radiation oncology
    Michael Orth, Kirsten Lauber, Maximilian Niyazi, Anna A. Friedl, Minglun Li, Cornelius Maihöfer, Lars Schüttrumpf, Anne Ernst, Olivier M. Niemoeller, Claus Belka · 2013 · Radiation and Environmental Biophysics
  54. Microparticles in Angiogenesis
    Maria Carmen Martínez, Ramaroson Andriantsitohaina · 2011 · Circulation Research
  55. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications
    Ye Wang, Liya Wang, Cheng Yeh Chen, Xiaoyuan Chu · 2018 · Molecular Cancer
  56. Rho GTPases modulate malignant transformation of tumor cells
    José Luis Orgaz, Cecilia Herráiz, Victoria Sanz‐Moreno · 2014 · Small GTPases
  57. Tumour vasculature at single-cell resolution
    Xu Pan, Xin Li, Liang Dong, Teng Liu, Min Zhang, Lining Zhang, Xiyuan Zhang, Lingjuan Huang, Wensheng Shi, Hongyin Sun et al. · 2024 · Nature
  58. Molecular Cross-Talk between the NFκB and STAT3 Signaling Pathways in Head and Neck Squamous Cell Carcinoma
    CRISTIANE HELENA SQUARIZE, ROGERIO MORAES CASTILHO, Virote Sriuranpong, Décio dos Santos Pinto Júnior, Jorge Silvio Gutkind · 2006 · Neoplasia
  59. Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras–Directed Therapy
    Fleming, Jason B., Shen, Guo-Liang, Holloway, Shane E., Davis, Mishel, Brekken, Rolf A. · 2005 · Molecular Cancer Research
  60. Cancer micrometastasis and tumour dormancy
    Harriet Wikman, Robert L. Vessella, Klaus Pantel · 2008 · Apmis
  61. Snail and E47 repressors ofE-cadherininduce distinct invasive and angiogenic properties in vivo
    Héctor Peinado, Faustino Marı́n, Eva Cubillo, Hans‐Jürgen Stark, Norbert E. Fusenig, Maria Angela Nieto, Amparo Cano · 2004 · Journal of Cell Science
  62. How molecular imaging is speeding up antiangiogenic drug development
    Weibo Cai, Jianghong Rao, Sanjiv Sam Gambhir, Xiaoyuan Shawn Chen · 2006 · Molecular Cancer Therapeutics
  63. Exosomes Function in Pro- and Anti-Angiogenesis
    Mara Fernandes Ribeiro, Hongyan Zhu, Ronald Wesley Millard, Guo‐Chang Fan · 2013 · Current Angiogenesis
  64. The Role of the Vascular Endothelial Growth Factor–Delta-like 4 Ligand/Notch4-Ephrin B2 Cascade in Tumor Vessel Remodeling and Endothelial Cell Functions
    Patricia Hainaud, Jean-Olivier Contrerès, Aude Villemain, Lang-Xia Liu, Jean Plouët, Gérard Tobelem, Évelyne Dupuy · 2006 · Cancer Research
  65. Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review
    Fotis Perlikos, Kevin Joseph Harrington, Konstantinos Nikolaos Syrigos · 2013 · Critical Reviews in Oncology/Hematology
  66. In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models
    Sang Hoon Lee, Daniel Lopes De Menezes, Jayesh Vora, Alex L. Harris, Helen Ye, Lara Nordahl, Evelyn N. Garrett, Emil E. Samara, Sharon L. Aukerman, Arnold Bruce Gelb et al. · 2005 · Clinical Cancer Research
  67. Cell adhesion molecules and their relation to (cancer) cell stemness
    Ensieh Farahani, Hirak Kumar Patra, Jaganmohan Reddy Jangamreddy, Iran Rashedi, M Kawalec, Rama Krishna Rao Pariti, Petros Batakis, Emilia Wiecheć · 2014 · Carcinogenesis
  68. Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
    Gianluca Masi, Lisa Salvatore, Luca Boni, Fotios Loupakis, Chiara Cremolini, Lorenzo Fornaro, Marta Schirripa, S. Cupini, C. Barbara, Valentina Safina et al. · 2015 · Annals of Oncology
  69. Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
    Maria Georganaki, Luuk van Hooren, Anna Dimberg · 2018 · Frontiers in Immunology
  70. New concepts in the diagnosis and management of choroidal metastases
    Thibaud Mathis, Pauline Jardel, Olivier Loria, Benoît Delaunay, Anh-Minh Nguyen, Francesco Baldo Lanza, Carlo Mosci, Jean‐Pierre Caujolle, Laurent Kodjikian, Juliette Thariat · 2018 · Progress in Retinal and Eye Research
  71. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
    Ryan A. Wilcox, David A. Wada, Steven C. Ziesmer, Sherine F. Elsawa, Nneka I. Comfere, Allan B. Dietz, Anne Josephine Novak, Thomas Elmer Witzig, Andrew L. Feldman, Mark R. Pittelkow et al. · 2009 · Blood
  72. Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
    Mario Leonardo Squadrito, Michele De Palma · 2011 · Molecular Aspects of Medicine
  73. Modulation of the tumor vasculature and oxygenation to improve therapy
    Siemann, Dietmar W., Horsman, Michael R. · 2015 · Pharmacology & Therapeutics
  74. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours
    Sébastien Toffoli, Carine Michiels · 2008 · FEBS Journal
  75. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1
    Anna B. Starzec, Roger Vassy, Antoine Martin, Marc Lecouvey, Mélanie Di Benedetto, Michel Crépin, Gérard Yves Perret · 2006 · Life Sciences
  76. Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration
    Steven Suchting, Paul Heal, Kiki Tahtis, LORNA M. D. STEWART, Roy Bicknell · 2004 · The FASEB Journal
  77. VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
    Nikolaos G. Gavalas, Marinos L Tsiatas, Ourania Tsitsilonis, Ekaterini Politi, Kyriaki Ioannou, Apostolos C Ziogas, Alexandros Rodolakis, George D. Vlachos, Nikolaos Thomakos, Dimitrios A. Haidopoulos et al. · 2012 · British Journal of Cancer
  78. Knockout of HIF-1 in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses
    Christian Werno, Heidi Menrad, Andreas Weigert, Nathalie Dehne, Sergij Goerdt, Kai Schledzewski, Julia G. Kzhyshkowska, Bastian Brune · 2010 · Carcinogenesis
  79. VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
    Apostolos C Ziogas, Nikos G. Gavalas, Marinos L Tsiatas, Ourania Tsitsilonis, Ekaterini Politi, Evangelos Terpos, Alexandros Rodolakis, George D. Vlachos, Nikolaos Thomakos, Dimitrios A. Haidopoulos et al. · 2011 · International Journal of Cancer
  80. Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro
    Yoshito Takeda, Alexander R. Kazarov, Catherine Butterfield, Benjamin David Hopkins, Laura E. Benjamin, Arja Kaipainen, Martin E. Hemler · 2006 · Blood
  81. Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells
    Zaid Altaany, Guangdong Yang, Rui Wang · 2013 · Journal of Cellular and Molecular Medicine
  82. Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression
    Reis, Marco, Czupalla, Cathrin J., Ziegler, Nicole, Devraj, Kavi, Zinke, Jenny, Seidel, Sascha, Heck, Rosario, Thom, Sonja, Macas, Jadranka, Bockamp, Ernesto et al. · 2012 · Journal of Experimental Medicine
  83. Shaping the brain vasculature in development and disease in the single-cell era
    Thomas Wälchli, Jeroen Bisschop, Peter Carmeliet, Gelareh Mohammed Zadeh, Philippe Patrick Monnier, Katrien De Bock, Ivan Radovanovic · 2023 · Nature reviews. Neuroscience
  84. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.
    Shigetomo Fukuhara, Keisuke Sako, Kazuomi Noda, Jianghui Zhang, Masayoshi MINAMI, Naoki Mochizuki · 2010 · PubMed
  85. Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development
    Nadya Dimitrova, Vasilena Gocheva, Arjun J. Bhutkar, Rebecca Resnick, Robyn M. Jong, Kathryn M. Miller, Jordan Bendor, Tyler Jacks · 2016 · Cancer Discovery
  86. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation
    Zhou, Yaxin, Ren, Xiaomeng, Hou, Zhaosheng, Wang, Ningning, Jiang, Yue, Luan, Yuxia · 2021 · Nanoscale Horizons
  87. Ionizing Radiation Induces Stemness in Cancer Cells
    Laura Ghisolfi, Andrew C. Keates, Xingwang Hu, Dong-ki Lee, Chiang J. Li · 2012 · PLoS ONE
  88. Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movement
    Patricia Rousselle, Jean‐Yves Scoazec · 2019 · Seminars in Cancer Biology
  89. A review on pro- and anti-angiogenic factors as targets of clinical intervention
    Diane Bouïs, Yoka H. Kusumanto, C MEIJER, N MULDER, Geke A.P. Hospers · 2005 · Pharmacological Research
  90. Addicted to Death
    Herbert J. Zeh, Michael T. Lotze · 2004 · Journal of Immunotherapy
  91. Somatostatin analogues: Multiple roles in cellular proliferation, neoplasia, and angiogenesis
    Piyali Dasgupta · 2004 · Pharmacology & Therapeutics
  92. Barriers to immune cell infiltration in tumors
    Marit Martina Melssen, Natasha Sheybani, Katie M. Leick, Craig Lee Slingluff · 2023 · Journal for ImmunoTherapy of Cancer
  93. Angiogenesis in multiple myeloma
    Christian Jakob, Jan Sterz, Ivana Zavrski, Ulrike Heider, Lorenz Kleeberg, Claudia Fleissner, Martin Kaiser, Orhan Sezer · 2006 · European Journal of Cancer
  94. Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy
    Qiaoling Sun, Jinghong Zhou, Zheng Zhang, Mingchuan Guo, Junqing Liang, Feng Zhou, Jingwen Long, Wei Zhang, Fang Yin, Huaqing Cai et al. · 2014 · Cancer Biology & Therapy
  95. Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
    Ayesha B. Alvero, Han‐Hsuan Fu, Jennie C. Holmberg, Irene Visintin, Liora Mor, Carlos Cano Marquina, Jessica Oidtman, Dan‐Arin Silasi, Gil Mor · 2009 · Stem Cells
  96. Metronomic chemotherapy and immunotherapy in cancer treatment
    Yu‐Li Chen, Ming-Cheng Chang, Wen‐Fang Cheng · 2017 · Cancer Letters
  97. The cancer matrisome: From comprehensive characterization to biomarker discovery
    Alexandra M. Socovich, Alexandra Naba · 2018 · Seminars in Cell and Developmental Biology
  98. Antiangiogenic Cancer Therapy: Monitoring with Molecular US and a Clinically Translatable Contrast Agent (BR55)
    Marybeth A. Pysz, Kira Foygel, Jarrett Rosenberg, Sanjiv Sam Gambhir, Michel Schneider, Jürgen K. Willmann · 2010 · Radiology
  99. Role of Notch signaling in colorectal cancer
    Qiao, L., Wong, B. C.Y. · 2009 · Carcinogenesis
  100. Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword
    Luan Pereira Diniz, Isadora C. Pereira Matias, Michele Siqueira, Joice Stipursky, Flávia Carvalho Alcântara Gomes · 2018 · Molecular Neurobiology